-
Sharp Gets MHRA Approval for Clinical Services CoE
ontractpharma
April 16, 2019
Can now offer a range of clinical and commercial services from the $12 million facility.
-
Three Key Challenges for Wide-Scale AI Adoption in Pharma
contractpharma
April 15, 2019
Loubna Bouarfa of OKRA Technologies discusses how to transform the challenges into tremendous opportunity...
-
Catalent Inaugurates Second Shanghai Facility
contractpharma
April 15, 2019
To optimize global and local clinical supply solutions for China.
-
Brexit will have ‘minimal’ effect on R&D, expert says
europeanpharmaceuticalreview
April 12, 2019
Jonathan Sheffield, OBE, was presenting at the PING (Pharmaceutical Industry Network Group) Brexit Conference 2019 in Hertfordshire, UK…
-
Precision NanoSystems launches Clinical Solutions service
cphi-online
April 12, 2019
Clinical Solutions offers clients a flexible, customizable suite of products and services designed to accelerate the clinical and commercial development of Gene and Cell Therapies...
-
Pacific Biomarkers Merges with Neomed-Labs
contractpharma
November 22, 2018
Benoit Bouche to serve as chief executive of the combined company
-
Vietnam, Quintiles enter deal to advance clinical trials
biospectrumasia
October 29, 2018
Vietnam, Quintiles enter deal to advance clinical trials
-
Mundipharma, Novartis to distribute pain medicine in SE Asia
biospectrumasia
September 29, 2018
Novartis will retain all international development responsibility, as well as clinical development activities.
-
Xspray Pharma Announces Positive Clinical Data for Its Lead Product Candidate HyNap-Dasa
pharmafocusasia
September 10, 2018
Xspray Pharma AB announces positive data from a clinical bioequivalence study with the company's lead product candidate HyNap-Dasa. The study results confirmed its primary aim to show bioequivalence of an optimized formulation of HyNap-Dasa compared to Sp
-
Jacobio Pharma raises $55 M in series C round
biospectrumasia
September 03, 2018
The company intends to use the proceeds garnered from the round on clinical research of JAB-3000 in China and the US.